Melanoma shows particular sensitivity to copper toxicity due to its metabolic characteristics: 35%–50% of wild-type, BRAF-mutant, and patient-derived melanoma cells rely heavily on oxidative phosphorylation (OXPHOS) for energy, making them sensitive to copper-induced mitochondrial damage (Fischer et al., 2018). The gene discussed is BRAF; the disease is melanoma.